CLINICAL APPLICATION OF BONE MORPHOGENETIC PROTEIN ON FRACTURE HEALING PROCESS
Downloads
Salomon L, Warwick D, Nayagam S. Apley's System of Orthopaedics and Fractures. 9th ed. London: Hodder Arnold; 2010.
Dimitriou R, Tsiridis E, Giannoudis PV (2005) Current concepts of molecular aspects of bone healing. Injury 36:1392–1404.
Komatsu DE, Warden SJ (2010) The control of fracture healing and its therapeutic targeting: improving upon nature. J Cell Biochem 109:302–311.
Urist MR (1965) Bone: formation by autoinduction. Science 150:893–899.
Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA (2003) Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 10:1735–1743.
Tsiridis E, Upadhyay N, Giannoudis P (2007) Molecular aspects of fracture healing: which are the important molecules? Injury 38 (Suppl 1):S11–S25.
Miyazono K, Kamiya Y, Morikawa M (2010) Bone morphogenetic protein receptors and signal transduction. J Biochem 147:35–51.
Sipe JB, Zhang J, Waits C, Skikne B, Garimella R, Anderson HC(2004) Localization of bone morphogenetic proteins (BMPs)-2, -4,and -6 within megakaryocytes and platelets. Bone 35:1316–1322.
Pecina M, Vukicevic S (2007) Biological aspects of bone, cartilage and tendon regeneration. Int Orthop 31:719–720.
Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A:2123– 2134.
Calori GM, Tagliabue L, Gala L, d'Imporzano M, Peretti g, Albisetti W (2008) Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients. Injury 39:1391–1402.
Giannoudis PV, Tzioupis C. (2005) Clinical applications of BMP-7: the UK perspective. Injury 36(Suppl 3):S47–S50.
Katayama Y, Matsuyama Y, Yoshihara H, et al. (2009). Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study. Int Orthop 33:1061–1067.
Varady P, Li JZ, Cunningham M, Beres EJ, et al. (2001). Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 12:697–710.
Yilgor P, Hasirci N, Hasirci V. (2010). Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A 93:528–536.
Boerckel JD, Kolambkar YM, Dupont KM, Uhrig BA, et al. (2011). Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 32:5241–5251.
Ristiniemi J, Flinkkilä T, Hyvönen P, Lakovaara M, Pakarinen H, Jalovaara P. (2007) RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation. J Bone Joint Surg Br 89:265–272.
Barr T, McNamara AJ, Sándor GK, Clokie CM, Peel SA. (2010) Comparison of the osteoinductivity of bioimplants containing recombinant human bone morphogenetic proteins 2 (Infuse) and 7 (OP-1). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:531–540.
Tazaki J, Murata M, Akazawa T, Yamamoto M, Ito K, Arisue M, Shibata T, Tabata Y. (2009) BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate. Biomed Mater Eng 19:141–146.
Dean DB, Watson JT, Moed BR, Zhang Z (2009) Role of bone morphogenetic proteins and their antagonists in healing of bone fracture. Front Biosci 14:2878–2888.
A.L. Jones, R.W. Bucholz, M.J. Bosse, S.K. Mirza, T.R. Lyon, L.X. Webb, A.N. Pollak, J.D. Golden, A. Valentin-Opran, Group BMPEiSfTT-AS, Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial, J. Bone Joint Surg. Am. 88 (2006) 1431–1441.
J.M. Wozney, V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, R.W. Kriz, R.M. Hewick, E.A. Wang, Novel regulators of bone formation: molecular clones and activities, Science 242 (1988) 1528–1534.
- The author acknowledges that the copyright of the article is transferred to the Journal of Orthopaedi and Traumatology Surabaya (JOINTS), whilst the author retains the moral right to the publication.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License (CC BY-NC-SA).
- All published manuscripts, whether in print or electronic form, are open access for educational, research, library purposes, and non-commercial uses. In addition to the aims mentioned above, the editorial board is not liable for any potential violations of copyright laws.
- The form to submit the manuscript's authenticity and copyright statement can be downloaded here.
Journal of Orthopaedi and Traumatology Surabaya (JOINTS) is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.
Journal Orthopaedi and Traumatology Surabaya (JOINTS) (